Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Afjal H Miah

Showing results (1-10 of 17) with videos related to

Pageof 2
Sort By:
The Journal of Organic Chemistry|February 3, 2025
Factors to Consider for Synthesis in 1536-Well Plates─An Amide Coupling Case Study for PROTAC SynthesisRebecca Stevens, Harry E P Palmer, Afjal H Miah, et al.
Organic & Biomolecular Chemistry|February 12, 2014
Lead identification and structure-activity relationships of heteroarylpyrazole arylsulfonamides as allosteric CC-chemokine receptor 4 (CCR4) antagonistsAfjal H Miah, Royston C B Copley, Daniel O'Flynn, et al.
Bioorganic & Medicinal Chemistry|August 13, 2017
Identification of pyrazolopyrimidine arylsulfonamides as CC-chemokine receptor 4 (CCR4) antagonistsAfjal H Miah, Aurelie C Champigny, Rebecca H Graves, et al.
Chemical Society Reviews|April 10, 2024
Innovative, combinatorial and high-throughput approaches to degrader synthesisRebecca Stevens, James D F Thompson, Julie C L Fournier, et al.
RSC Medicinal Chemistry|December 25, 2024
Expanding the reaction toolbox for nanoscale direct-to-biology PROTAC synthesis and biological evaluationRebecca Stevens, Harry J Shrives, Jenni Cryan, et al.
ACS Chemical Biology|June 13, 2015
HaloPROTACS: Use of Small Molecule PROTACs to Induce Degradation of HaloTag Fusion ProteinsDennis L Buckley, Kanak Raina, Nicole Darricarrere, et al.
ACS Chemical Biology|June 30, 2026
A Systematic Direct-to-Biology Approach Identified Potent Cereblon HaloPROTACsRebecca Stevens, Kwok-Ho Chan, Alice Moore, et al.
Bioorganic & Medicinal Chemistry|June 10, 2014
Lead identification of benzimidazolone and azabenzimidazolone arylsulfonamides as CC-chemokine receptor 4 (CCR4) antagonistsAfjal H Miah, Hossay Abas, Malcolm Begg, et al.
Journal of Medicinal Chemistry|November 7, 2023
Integrated Direct-to-Biology Platform for the Nanoscale Synthesis and Biological Evaluation of PROTACsRebecca Stevens, Enrique Bendito-Moll, David J Battersby, et al.
European Journal of Medicinal Chemistry|March 19, 2016
2,8-Diazaspiro[4.5]decan-8-yl)pyrimidin-4-amine potent CCR4 antagonists capable of inducing receptor endocytosisLena Shukla, Laura A Ajram, Malcolm Begg, et al.
Pageof 2

Showing results (1-10 of 17) with videos related to

Sort By:
Pageof 2
The Journal of Organic Chemistry|February 3, 2025
Factors to Consider for Synthesis in 1536-Well Plates─An Amide Coupling Case Study for PROTAC SynthesisRebecca Stevens, Harry E P Palmer, Afjal H Miah, et al.
Organic & Biomolecular Chemistry|February 12, 2014
Lead identification and structure-activity relationships of heteroarylpyrazole arylsulfonamides as allosteric CC-chemokine receptor 4 (CCR4) antagonistsAfjal H Miah, Royston C B Copley, Daniel O'Flynn, et al.
Bioorganic & Medicinal Chemistry|August 13, 2017
Identification of pyrazolopyrimidine arylsulfonamides as CC-chemokine receptor 4 (CCR4) antagonistsAfjal H Miah, Aurelie C Champigny, Rebecca H Graves, et al.
Chemical Society Reviews|April 10, 2024
Innovative, combinatorial and high-throughput approaches to degrader synthesisRebecca Stevens, James D F Thompson, Julie C L Fournier, et al.
RSC Medicinal Chemistry|December 25, 2024
Expanding the reaction toolbox for nanoscale direct-to-biology PROTAC synthesis and biological evaluationRebecca Stevens, Harry J Shrives, Jenni Cryan, et al.
ACS Chemical Biology|June 13, 2015
HaloPROTACS: Use of Small Molecule PROTACs to Induce Degradation of HaloTag Fusion ProteinsDennis L Buckley, Kanak Raina, Nicole Darricarrere, et al.
ACS Chemical Biology|June 30, 2026
A Systematic Direct-to-Biology Approach Identified Potent Cereblon HaloPROTACsRebecca Stevens, Kwok-Ho Chan, Alice Moore, et al.
Bioorganic & Medicinal Chemistry|June 10, 2014
Lead identification of benzimidazolone and azabenzimidazolone arylsulfonamides as CC-chemokine receptor 4 (CCR4) antagonistsAfjal H Miah, Hossay Abas, Malcolm Begg, et al.
Journal of Medicinal Chemistry|November 7, 2023
Integrated Direct-to-Biology Platform for the Nanoscale Synthesis and Biological Evaluation of PROTACsRebecca Stevens, Enrique Bendito-Moll, David J Battersby, et al.
European Journal of Medicinal Chemistry|March 19, 2016
2,8-Diazaspiro[4.5]decan-8-yl)pyrimidin-4-amine potent CCR4 antagonists capable of inducing receptor endocytosisLena Shukla, Laura A Ajram, Malcolm Begg, et al.
Pageof 2